4
Changes in Ownership
Traws Pharma, Inc. Filed Acc 0002018150-25-000003
Options or other derivatives
- Chief Science Officer Virology acquired 32,406 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Pauza Charles David · Chief Science Officer Virology
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-12 | Grant or award : show line 1 in the form Stock Option (right to purchase) | +32,406 | 32,406 | D |
Loading xslF345X05/form4-10162025_121042.xml…